ELVN - Enliven Therapeutics, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$43.33
DETAILS
HIGH:
$52.00
LOW:
$39.00
MEDIAN:
$39.00
CONSENSUS:
$43.33
DOWNSIDE:
4.39%
Market Cap:
2.71B
Volume:
1,089,784
Avg Volume:
1,339,096
52 Week Range:
14.45-46.3
Sector:
Healthcare
Industry:
Biotechnology
Beta:
0.49
Last Dividend:
$N/A
Exchange:
NASDAQ
Country:
US
Employees:
62
IPO Date:
2020-03-12